Sickle cell patients and their families are speaking out, saying their pain is being treated with a one-size-fits-all ...
Chronic pain in young people with sickle cell disease means greater disability, more burden, and lower quality of life, a U.S ...
Learn about the global clinical trial for sickle cell disease aimed at improving quality of life and addressing anemia.
A Black female doctor when that was rare, she developed a diagnostic test for the disease that is still a standard tool, as ...
Under the agreement, participating states will receive “discounts and rebates” from the drugmakers if the treatments don’t ...
Columnist Michelle Harlan, who's currently taking hydroxyurea to treat her sickle beta-zero thalassemia, considers some other ...
Join the ELRIG conference to hear from experts on cell and gene therapy. Discover advancements shaping the future of medicine.
The market size of CGT products is expected to continue to rise by 2031 and reach $63 billion. CGTs have yielded commercial gains for several pharma companies. For example, some of the top-selling CGT ...
Caring Cross, a 501(c)(3) non-profit dedicated to improving access to advanced therapies, and Boston Children's Hospital today announced a collaboration to provide a sustainable, affordable pathway ...
The government is using sickle cell treatments to test a new strategy: paying only if the therapies benefit patients.
NEW YORK – Boston Children's Hospital has granted a worldwide license for an investigational gene therapy for sickle cell disease and beta thalassemia to Caring Cross, the nonprofit announced this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results